Albuvirtide Uses, Dosage, Side Effects and more
Albuvirtide is under investigation in clinical trial NCT03719664 (Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed Subjects).
| Trade Name | Albuvirtide |
| Generic | Albuvirtide |
| Type | |
| Formula | C204H306N54O72 |
| Weight | Average: 4666.998 Monoisotopic: 4664.194308709 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
